Tue, 04/23/2024 - 11:30 |
Celegence Receives MBE Certification Renewal Two Years in a Row |
celegence |
Thu, 12/29/2022 - 12:57 |
Justice Department Files Nationwide Lawsuit Against AmerisourceBergen Corp. and Subsidiaries for Controlled Substances Act Violations |
DOJ |
Fri, 12/23/2022 - 15:33 |
CHPA Statement on Congress Passing FY 2023 Omnibus Appropriations Bill |
CHPA |
Fri, 12/23/2022 - 12:13 |
Congress Year-End Legislative Package Delivers for the Rare Community |
NORD |
Tue, 12/20/2022 - 14:55 |
McDonalds Quietly Updates Policies on Antibiotic Use in Beef Supplies, Continues Touting Empty Promises |
NRDC |
Mon, 12/19/2022 - 14:59 |
Federal Court Enters Consent Decree Against Oklahoma Drug Compounder |
FDA |
Wed, 12/14/2022 - 22:47 |
Looking Ahead: Medicare in 2023 and Beyond |
Medicare Rights... |
Wed, 12/14/2022 - 22:46 |
Medicare in 2022: The Year in Review |
Medicare Rights... |
Wed, 12/14/2022 - 18:36 |
HHS Proposes Rule to Strengthen Beneficiary Protections, Improve Access to Behavioral Health Care, and Promote Equity for Millions of Americans with Medicare Advantage and Medicare Part D |
HHS |
Wed, 12/14/2022 - 07:23 |
eHealth Insights 2022 Retrospective: A Deeper Understanding of Medicare Beneficiaries' Sentiments & Experiences |
eHealthInsurance |
Thu, 12/08/2022 - 11:18 |
3 Automation Outcomes for Pharmacovigilance and Safety Teams |
TransPerfect |
Tue, 12/06/2022 - 16:13 |
District Court Orders Oklahoma Drug Compounder to Comply with Federal Food, Drug, and Cosmetic Act |
DOJ |
Sun, 12/04/2022 - 20:51 |
Lupin Launches Rufinamide Tablets USP in the United States |
Lupin |
Sun, 12/04/2022 - 20:39 |
Survey Shows Increase in Abuse of Cough and Cold Medicines Among 10th Graders, But Rates Among Youth Remain Relatively Low |
CHPA |
Thu, 12/01/2022 - 10:28 |
Value Created by OTC Medicines Generates Billions in Savings to the U.S. Healthcare System |
CHPA |
Thu, 12/01/2022 - 08:18 |
New Analysis Offers Data-Driven Plan for FDA to Curb Unnecessary Antibiotic Use in Livestock |
NRDC |
Tue, 11/29/2022 - 10:32 |
Resilience to Establish a Biomanufacturing Partnership with AstraZeneca and Purchase AstraZenecas Manufacturing Site in West Chester, Ohio |
Resilience |
Mon, 11/28/2022 - 10:54 |
Lexicon Pharmaceuticals to Participate in the 34th Annual Piper Sandler Healthcare Conference and the 5th Annual Evercore ISI HealthCONx Conference |
Lexicon Pharmac... |
Mon, 11/28/2022 - 10:12 |
Doctor Pleads Guilty to Using Misbranded and Adulterated Products Sold as Botox and Juvederm |
DOJ |
Mon, 11/21/2022 - 14:12 |
MSF begins using Antibiogo application to tackle antibiotic resistance |
Doctors Without... |
Fri, 11/18/2022 - 10:26 |
Quadripartite launches a new platform to tackle antimicrobial resistance threat to human and animal health and ecosystems |
WHO |
Thu, 11/17/2022 - 17:11 |
Arizona Communities Team up with DEA & Partners Turning in 4 Tons of Unneeded Prescription Medications |
Drug Enforcemen... |
Thu, 11/17/2022 - 09:14 |
Alliance Healthcare and GIRP, the European Healthcare Distribution Association, Host Antimicrobial Resistance (AMR) Event |
AmerisourceBergen |
Wed, 11/16/2022 - 08:07 |
FDA Issues Final Rule on Food Traceability |
NACS |
Tue, 11/15/2022 - 18:30 |
New Analysis Shows Significant Savings to Medicare Patients, Limited Budgetary Impact of Flat Copayment Policy for Prescription Drugs |
Alliance for Ag... |